Consistent with the in vitro data, these tumor-infiltrating macrophages also showed increased ROS levels, enhanced caspase-1 activity and elevated mature IL-1β production following L-MP treatment (Fig. 6c–f). The gene discussed is CASP1; the disease is neoplasm.